Moderna (MRNA)Officer filed to sell ~$8.64M

~$8.64M

planned to sell · 39K shares, around Oct 15, 2026

Planned for

Oct 15, 2026

Notice filed

Oct 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 19, 2026Congress · 1 personMembers of Congress: 1 purchase, 1 sale
2. Aug 27, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 2 more items)
3. Sep 1, 2026InsiderOfficer sold ~$486K of MRNA shares in the open market
4. Sep 10, 2026Insider · 1 personInsiders: 2 sales (~$4.7M)
5. Sep 14, 2026InsiderOfficer sold ~$5.81M of MRNA shares in the open market
6. Sep 15, 2026InsiderOfficer sold ~$5.88M of MRNA shares in the open market
7. Sep 24, 2026CongressDisclosed partial sale of MRNA — reported range $1,001 - $15,000
8. Sep 30, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 30, 2026, Moderna, Inc. (“Moderna” or the “Company”) announced the appointment of Juan Andres as its Chief Operating Officer (“COO”) effective October 5, 2026.”
9. Oct 14, 2026Insider · 1 personInsiders: 2 sales (~$8.4M)
10. Oct 15, 2026InsiderOfficer sold ~$8.64M of MRNA shares in the open market

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Moderna

For Moderna, OQRO holds 17 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRNA page.

How this filing works

• SEC Form 144
• Rule 10b5-1 trading plans

Other disclosures at Moderna

• SEC Form 4Oct 16, 2026
• SEC Form 4Oct 16, 2026
• SEC Form 4Oct 16, 2026
• SEC Form 144Oct 14, 2026
• House Clerk periodic transaction reportOct 7, 2026
• SEC Form 4Sep 16, 2026

Everything OQRO holds on this company is on its MRNA page.